Browse by author
Lookup NU author(s): Dr Georgina Carr,
Professor Nicholas Simmons,
Professor John SayerORCiD
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Mutations in CLCN5, which encodes the voltage-dependent Cl-/H +antiporter, CLC-5, cause Dent's disease. This disorder is characterized by low molecular-weight proteinuria, hypercalciuria, nephrocalcinosis and nephrolithiasis. Using a collecting duct cell model (mIMCD-3) in which endogenous clc-5 is disrupted by antisense clc-5 or overexpression of truncated clc-5, we demonstrate altered expression of the crystal adhesion molecule, annexin A2. Endogenously expressed annexin A2 is intracellular with limited plasma membrane localization. Following clc-5 disruption, there is both a marked increase in plasma membrane annexin A2 and an increase in cell surface crystal retention and agglomeration, which may be attenuated using pretreatment with anti-annexin A2 antibodies or wheat germ agglutinin lectin but not by concanavalin A. We hypothesize that in Dent's disease, endocytic failure leads to an accumulation at the plasma membrane of crystal-binding molecules that include annexin A2 leading to retention of calcium crystals and ultimately nephrocalcinosis and nephrolithiasis. © Birkhäuser Verlag, 2006.
Author(s): Carr G, Simmons NL, Sayer JA
Publication type: Article
Publication status: Published
Journal: Cellular and Molecular Life Sciences
ISSN (print): 1420-682X
ISSN (electronic): 1420-9071
Publisher: Birkhaeuser Verlag AG
PubMed id: 16429322
Altmetrics provided by Altmetric